A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Anne V Soerensen, Poul F Geertsen, Ib J Christensen, Gregers G Hermann, Niels V Jensen, Kirsten Fode, Astrid Petersen, Rickard Sandin, Frede Donskov
Dive into the research topics of 'A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2'. Together they form a unique fingerprint.